Clinical Trial: A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Head and Neck Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase II Trial of Xevinapant in Combination With Post-Operative Cisplatin and Radiotherapy for High Risk Head and Neck Cancer
Brief Summary:
The purpose of this study is to test whether treatment with Xevinapant added to standard chemoradiation after surgery is an effective treatment for people with high-risk head and neck cancers.
Read more